A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma

Type of Cancer
Neuro-Oncology

Site
Hackensack

Sponsor
Bristol-Myers Squibb

Protocol Number
CA209-548

To Learn More Call
201-510-0910